|
Q2 FY2018
As of Jul 31, 2017
|
Q1 FY2018
As of Apr 30, 2017
|
Q4 FY2017
As of Jan 31, 2017
|
Q3 FY2017
As of Oct 31, 2016
|
Q2 FY2017
As of Jul 31, 2016
|
Q1 FY2017
As of Apr 30, 2016
|
Q4 FY2016
As of Jan 31, 2016
|
Q3 FY2016
As of Oct 31, 2015
|
Q2 FY2016
As of Jul 31, 2015
|
Q1 FY2016
As of Apr 30, 2015
|
Q4 FY2015
As of Jan 31, 2015
|
Q3 FY2015
As of Oct 31, 2014
|
Q2 FY2015
As of Jul 31, 2014
|
Q1 FY2015
As of Apr 30, 2014
|
Q4 FY2014
As of Jan 31, 2014
|
Q3 FY2014
As of Oct 31, 2013
|
Q2 FY2014
As of Jul 31, 2013
|
Q1 FY2014
As of Apr 30, 2013
|
Q4 FY2013
As of Jan 31, 2013
|
Q3 FY2013
As of Oct 31, 2012
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Current portion of deferred revenue | ||||||||||||||||||||
| Current portion of capital lease obligations | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Capital lease obligations | ||||||||||||||||||||
| Deferred rent | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding | ||||||||||||||||||||
| Common stock, $0.001 par value; 30,000,000 shares authorized; 15,047,030 and 14,926,429 shares issued, respectively; 15,014,528 and 14,893,927 shares outstanding, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Treasury stock (32,502 common shares, at cost) | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
